Search by Drug Name or NDC

    NDC 54436-0112-20 Tlando 112.5 mg/1 Details

    Tlando 112.5 mg/1

    Tlando is a ORAL CAPSULE, LIQUID FILLED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Antares Pharma, Inc.. The primary component is TESTOSTERONE UNDECANOATE.

    Product Information

    NDC 54436-0112
    Product ID 54436-112_25f914d5-0744-43fd-a6f2-32156697e646
    Associated GPIs 23100030800125
    GCN Sequence Number 083222
    GCN Sequence Number Description testosterone undecanoate CAPSULE 112.5 MG ORAL
    HIC3 F1A
    HIC3 Description ANDROGENIC AGENTS
    GCN 52120
    HICL Sequence Number 007304
    HICL Sequence Number Description TESTOSTERONE UNDECANOATE
    Brand/Generic Brand
    Proprietary Name Tlando
    Proprietary Name Suffix n/a
    Non-Proprietary Name testosterone undecanoate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, LIQUID FILLED
    Route ORAL
    Active Ingredient Strength 112.5
    Active Ingredient Units mg/1
    Substance Name TESTOSTERONE UNDECANOATE
    Labeler Name Antares Pharma, Inc.
    Pharmaceutical Class Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]
    DEA Schedule CIII
    Marketing Category NDA
    Application Number NDA208088
    Listing Certified Through 2024-12-31

    Package

    NDC 54436-0112-20 (54436011220)

    NDC Package Code 54436-112-20
    Billing NDC 54436011220
    Package 120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (54436-112-20)
    Marketing Start Date 2022-04-15
    NDC Exclude Flag N
    Pricing Information N/A